Home > Analytics > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Intrinsic Value | Fundamental Analysis

BOM : 500126     NSE : PGHL    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Jun 10,2025
Price(EOD): ₹ 5,804.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 9,636.05 Cr
Value of ₹ 1 Lac invested in PROCTER & GAMBLE HEALTH
on Jun 09,2020 (price: ₹ 4,240.40)

₹ 1 L

₹ 1.37 L

1W : -0.9% 1M : 13.1% 1Y : 15.5%
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
PROCTER & GAMBLE HEALTH -0.9% 13.1% 15.5%
SUN PHARMACEUTICAL INDUSTRIES 1.6% -2.9% 17.2%
DIVIS LABORATORIES 1.5% 10.4% 51.9%
CIPLA 2.3% 1.9% 2.8%
TORRENT PHARMACEUTICALS 1.4% 1.3% 17%
DR REDDYS LABORATORIES 5.7% 14.1% 15.2%
MANKIND PHARMA 0.2% -2.4% 12.5%
ZYDUS LIFESCIENCES 5.1% 10.9% -4.4%
LUPIN 2% -2.2% 27.9%

FUNDAMENTAL ANALYSIS OF PROCTER & GAMBLE HEALTH

 
Fundamentals Score
[ Q(TTM): Mar2025, Y: Jun2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 PGHL is one of the top 37% companies with good fundamentals ! Discover More →

VALUATION OF PROCTER & GAMBLE HEALTH

 
Valuation Score
[As on : Jun 10,2025 ]

Ratio Standalone
P/E
P/B
P/S
38.36
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 251.19 Cr
[Latest Qtr - Mar2025 - Standalone Results ]

18.19
P/B Calculated based on Book Value of Rs 529.71 Cr
[Latest Year - Jun2024 - Standalone Results ]

7.91
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2025 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 16% undervalued companies ! Discover More →

FAIR VALUE OF PROCTER & GAMBLE HEALTH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
88%
110%
60%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF PROCTER & GAMBLE HEALTH


Insights 💡 PGHL is one of the top 79% companies with bullish price momentum currently! Discover More →

PROCTER & GAMBLE HEALTH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF PROCTER & GAMBLE HEALTH

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Jun2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF PROCTER & GAMBLE HEALTH

Pledged Promoter Shares
0 %
As on : Mar2025

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF PROCTER & GAMBLE HEALTH

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
0.39%
-34.44%
-35.47%
-32.7%
23.17%
19.99%
25.21%
31.4%
QtrlyTrend
2
Latest Qtr: Mar2025
Quarterly Result Analysis →


PROCTER & GAMBLE HEALTH related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE 500 SHARIAH 4.3% 4.3% 1.1%
BSE 250 SMALLCAP INDEX 3.5% 15.6% 17.3%
BSE 400 MIDSMALLCAP INDEX 3.4% 12.4% 17%
NSE Indices1W1M1Y
NIFTY MIDSMALL HEALTHCARE 2.7% 5.4% 29.4%

You may also like the below Video Courses


FAQ about PROCTER & GAMBLE HEALTH


Is PROCTER & GAMBLE HEALTH good for long term investment?

As on Jun 10,2025, the Fundamentals of PROCTER & GAMBLE HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of PROCTER & GAMBLE HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is PROCTER & GAMBLE HEALTH UnderValued or OverValued?

As on Jun 10,2025, PROCTER & GAMBLE HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of PROCTER & GAMBLE HEALTH ?

As on Jun 10,2025, the Intrinsic Value of PROCTER & GAMBLE HEALTH is Rs. 3,082.63 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 3,082.63
Fair Value [Median EV / Sales Model] : Rs. 2,767.33
Fair Value [Median Price / Sales Model] : Rs. 3,625.95
Estimated Median Fair Value of PROCTER & GAMBLE HEALTH : Rs. 3,082.63

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is PROCTER & GAMBLE HEALTH trading at a Premium or Discount?

As on Jun 10,2025, PROCTER & GAMBLE HEALTH is trading at a Premium of 88% based on the estimates of Median Intrinsic Value!